Evaluating the Nexel Total Elbow for joint replacement
Official title: Retrospective and Prospective Clinical Outcomes Study of the Zimmer® Nexel™ Total Elbow
Run by Zimmer Biomet · NCT02469662 · Data updated 2026-11-12
This study is testing the Zimmer Nexel Total Elbow replacement to see how well it works and if it's safe for people getting elbow surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 134 (estimated) |
| Sponsor | Zimmer Biomet Industry-sponsored |
| Locations | 11 sites (Golden, Colorado and 10 other locations) |
| Status | Recruiting |
| Started | June 2015 |
| Main results expected | December 2035 |
| Study ends | December 2036 |
| Registry record updated | July 9, 2026 |
| Trial ID | NCT02469662 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults with significant elbow joint destruction, advanced rheumatoid arthritis, or other conditions leading to instability or loss of motion.
✕Probably not a fit
Patients with active infections or those who do not meet the criteria for total elbow arthroplasty may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to confirm the safety and performance of the Zimmer Nexel Total Elbow in patients undergoing primary or revision total elbow replacement. It will analyze outcomes using standard scoring systems, radiographic assessments, and records of adverse events. The study will evaluate pain relief, functional performance, device survival, and overall patient health status following the procedure.
Why it matters
Potential benefit: If successful, this could provide patients with improved pain management and functional outcomes following elbow replacement surgery.
How similar studies have gone: Other studies on total elbow arthroplasty have shown promising results, indicating that this approach is supported by existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient is 18 years of age or older. * Patient must have signed Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent. * Patient is a candidate for primary or revision total elbow arthroplasty, based on symptoms including at least one of the following: * Elbow joint destruction which significantly compromises daily living activities * Post-traumatic lesions or bone loss contributing to elbow instability * Ankylosed joints, especially cases of bilateral ankylosis from causes other than active sepsis * Advanced rheumatoid arthritis, post-traumatic, or degenerative arthritis with incapacitating pain * Instability or loss of motion when the degree of joint or soft tissue damage precludes reliable osteosynthesis * Acute comminuted articular fracture of elbow joint surfaces that precludes less radical procedures, including 13-C3 fractures of the distal humerus * Patient is willing and able to complete scheduled follow-up evaluations as defined by the protocol. Additional Retrospective Arm Inclusion Criteria * Patient must have undergone a total elbow replacement with the Nexel system between July 2013 and the date of the site initiation visit. * Patient information available for each retrospective patient must, at minimum, include preoperative demographic information, preoperative physical exam information, the index surgery operative report, and details of the devices implanted. Exclusion Criteria: * Patient has a currently active or history of repeated local infection at the surgical site. * Patient has a current major infection distant from the operative site. * Patient has a history of prior sepsis. * Patient suffers from paralysis or dysfunctional neuropathy at the elbow joint. * Patient has significant ipsilateral hand dysfunction. * Patient has excessive scarring near the surgical site, which could prevent adequate soft tissue coverage. * Patient participates in daily activities that may cause significant stress to an implanted device such as heavy labor, torsional stress, and/or competitive sports. * Patient is a prisoner. * Patient is mentally incompetent or unable to understand what participation in the study entails. * Patient is a known alcohol or drug abuser. * Patient is anticipated to be non-compliant. * Patient is known to be pregnant.
Where it's running
-
Panorama Orthopedics and Spine Center
Golden, Colorado, United States Recruiting -
OrthoCarolina Research Institute
Charlotte, North Carolina, United States Recruiting -
Rothman Institute
Philadelphia, Pennsylvania, United States Recruiting -
Campbell Clinic
Germantown, Tennessee, United States Recruiting -
Coxa Hospital
Tampere, Finland Recruiting -
AO Mauriziano
Torino, Italy Recruiting
Show 5 more locations
-
Wrightington
Wigan, United Kingdom Recruiting -
Sydney Shoulder & Elbow, NSW
Sydney, New South Wales, Australia Terminated -
Hôpital Purpan (Centre Hospitalier Universitaire Toulouse)
Toulouse, France Terminated -
Arcus Sportklinik
Pforzheim, Germany Terminated -
Amphia Ziekenhuis Breda
Breda, Netherlands Active not recruiting
Study contacts
- Study coordinator: Richard Marek
- Email: richard.marek@zimmerbiomet.com
- Phone: 574-453-7567
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Legion Medial Stabilized insert in total knee replacement
This study tests whether the Legion Medial Stabilized insert is safe and works well when used in primary knee replacements for people with osteoarthritis, inflammatory arthritis, or post-traumatic arthritis.
-
Follow-up of the Incompass Total Ankle System after total ankle replacement surgery.
The Incompass Total Ankle System will be followed to see if it is safe and helps reduce pain and improve quality of life in adults having total ankle replacement.
-
Assessing the KeriFlex® silicone joint implant for arthritis treatment
This study is testing how well the KeriFlex® silicone joint implant works and is safe for people with different types of arthritis who are getting joint replacement surgery.
-
Observational study on total wrist replacement outcomes with KinematX implant
This study is testing how well the KinematX wrist replacement helps people regain movement and strength in their wrist after surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.